Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

TrueHealth Medical lands on HKEX as the first Hong Kong-listed percutaneous surgical robotics player, with a 216.96% debut rally

HONG KONG SAR – EQS Newswire - 2 July 2026 - On June 30, 2026, Guangdong TrueHealth Medical Technology Development Co., Limited (referred to as "TrueHealth Medical" or the "Company", stock code: 02697.HK) has made its debut on the Main Board of the Hong Kong Stock Exchange, becoming the first HKEX-listed specialist in percutaneous surgical robotics.

At market close, the Company's stock settled at HK$400.0, representing an increase of HK$273.8 from its IPO offer price of HK$126.2, marking a 216.96% surge on its trading debut. Total trading volume hit HK$320 million, and the Company's total market capitalization stood at HK$14.259 billion based on the closing price.

TrueHealth Medical drew heavy investor attention on its trading debut, building on robust pre-listing gray market sentiment. Ahead of the IPO, Futu Securities' gray market sessions saw the stock hit a peak of HK$358, representing a 183.7% premium to the offer price. The upbeat market sentiment underscores strong investor appetite for the underserved niche segment of percutaneous puncture and ablation surgical robots.

Founded in 2018 as outlined in its prospectus, TrueHealth Medical specializes in the research, development and commercialization of percutaneous puncture and ablation robotic systems in China. Its flagship percutaneous surgical robot lineup comprises four variants: TH-S1, TH-S, TH-S Pro and TH-SA. All four hold Class III medical device registrations issued by the National Medical Products Administration (NMPA), cleared for navigation and positioning during percutaneous procedures on solid abdominal and pulmonary organs in adult patients. The TH-S model has received NMPA accreditation as a China-first innovation.

Beyond its core systems, the Company's pipeline extends to percutaneous microwave ablation robotics. Its flagship TH-X MW system, approved for liver and lung tumor treatment, has secured NMPA recognition as a world-first innovation, while the TH-X HMW system is cleared solely for liver tumor interventions. The Company holds a full-spectrum product matrix spanning puncture navigation and positioning, microwave ablation therapy and pipeline candidates.

On industry leadership, research from CIC Consulting ranks TrueHealth Medical as China's market leader by both shipment volume and revenue for percutaneous surgical robots in 2025, commanding respective market shares of 36.4% by shipment volume and 28.0% by revenue. As of the latest practicable date, 21 percutaneous surgical robotic systems have won NMPA approval nationwide, five of which belong to TrueHealth Medical – making the Company the earliest and most prolific developer of cleared devices in this specialized segment.

On commercialization, TrueHealth Medical booked annual revenues of RMB1.791 million in 2024 and RMB12.178 million in 2025. A total of six robotic systems were delivered throughout 2025, including two TH-S, one TH-P, one TH-S Pro and two TH-X MW. With an expanding roster of approved systems, broadening clinical adoption and maturing sales networks, the Company stands at a pivotal transition from product validation to scaled commercial growth.

Its Hong Kong listing equips TrueHealth Medical with capital markets backing to accelerate commercialization of core hardware, advance R&D for existing and pipeline systems, and scale manufacturing and go-to-market capabilities. The Company will continue building an intelligent robotics portfolio centered on percutaneous positioning and precision therapy, delivering cutting-edge minimally invasive solutions for oncology diagnosis and treatment.

Speaking at the listing ceremony, Cheong Hou Iam, the chairperson, executive director and general manager, commented: "TrueHealth Medical stays committed to resolving unmet clinical pain points via technological innovation. We focus on the R&D and commercialization of percutaneous puncture and ablation robotics. Drawing on deep technical expertise and extensive clinical validation, we iterate our products and broaden our offerings to build a robust moat in precision minimally invasive treatment. Surgical robotics is now entering a golden era, boosted by vast market prospects. Leveraging our first-mover advantage and industrial resources, we will capitalize on industry tailwinds, unlock full value and deliver sustainable returns to all our shareholders and investors."


Hashtag: #TrueHealthMedical

The issuer is solely responsible for the content of this announcement.

About TrueHealth Medical Technology Development Co., Limited

A nationally accredited "Little Giant" enterprise (Specialized, Sophisticated, Distinctive & Innovative), Guangdong TrueHealth Medical Technology Development Co., Limited leverages artificial intelligence and robotic control technologies to develop and commercialize intelligent robots for soft tissue puncture diagnosis and organ repair. Its core offerings cover percutaneous puncture navigation and microwave ablation guided systems. The ZhenYiDa® percutaneous puncture navigation and positioning system holds NMPA China-first certification, while the ZhenYiDa® navigation and positioning microwave ablation system is accredited as a world-first innovation by NMPA. The Company undertakes key projects under China's 14th Five-Year National Key R&D Program, with its products featured in national flagship schemes including high-end medical device roll-out initiatives, AI medical device innovation program and the Catalog of Outstanding Domestic Medical Devices. TrueHealth Medical aims to deploy AI and surgical robotics to advance precision, minimally invasive therapeutic solutions for widespread clinical use.

News from Asia

EBANX and Eneba strengthen partnership in Latin America with 138% YoY growth in payment volume

With Pix, Nequi, and Mercado Pago among the most used payment methods by Eneba’s customers, the operation now covers eight countries in the regionCURITIBA, BRAZIL – Media OutReach Newswire – 13 No...

L’OCCITANE Celebrates 50 Years Of Provençal Craftsmanship With Holiday 2026 Collection

Featuring a creative collaboration with artist Caroline Romain-Desfossés, the Maison marks its golden milestone with a festive collection inspired by the art of gifting. KUALA LUMPUR, MALAYSIA – ...

Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi Partners

Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for CancersHONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Yicura BioMed ("Yicura"), a clinical-stage immunotherapy ...

LOCUS-T and My Starfish Foundation Launch Illustrated Cancer Book to Make Cancer Information More Accessible

SHAH ALAM, MALAYSIA – Media OutReach Newswire – 13 November 2026 – Malaysian digital marketing agency LOCUS-T has joined hands with My Starfish Foundation (MSF) to launch What Do We Do Next? ...

From Message to Mandate: PRISM Summit 2026 Calls on Communicators to Claim Their Seat at the Governance Table

Inaugural Singapore State of PR and Communications Survey unveiled as senior communicators, journalists and board leaders gather at METT SingaporeSINGAPORE – Media OutReach Newswire – 13 November ...

Former Tencent Cloud AI Executive Eric Muqing Li Appointed Co-CEO of Education AI Company Qimingdaren

CHENGDU, CHINA – Media OutReach Newswire – 13 November 2026 – According to a report by Leiphone, Eric Muqing Li, formerly Head of Global Business at Tencent Cloud AI, has recently been appointed C...

Chongqing: Forging New Connections Across Eurasia — Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises Held

CHONGQING, CHINA - Media OutReach Newswire - 13 November 2026 - On November 12, the Industry Matchmaking Conference of Chongqing Visit by Eurasian Enterprises was held at Yuzhou Hotel. Around 700 ...

Bora Group 3Q26: Revenue and Net Income Expansion Continues U.S. Manufacturing and Biologics Footprint Complete; Margin Expansion to Follow as Utilization Improves

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 an...

CALL-E Lets AI Agents in ChatGPT, Muse and OpenClaw Make Real Phone Calls on Their Users' Behalf

Built by AI Rudder, CALL-E asks the user before every call and reports back with proof of what was agreed.SAN FRANCISCO, US – Media OutReach Newswire – 13 November 2026 – AI Rudder, the Singapore-...

11 Boutique Xinjiang Wineries to Debut in Singapore

The launch programme includes a one-day trade exhibition, Master of Wine masterclass and Michelin-starred pairing dinner, highlighting Xinjiang terroir.SINGAPORE - Media OutReach Newswire - 14 Nov...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...